Cure8 trial brief
Faster, reliable reading of capsule endoscopy videos could shorten diagnostic delays and make small-bowel evaluation easier for people with suspected Crohn’s disease. If AI preserves accuracy while reducing review time, it may change how centers handle capsule studies.
Adult patients with suspected Crohn’s disease, gastroenterologists/endoscopists who perform capsule endoscopy, and researchers developing or evaluating AI tools for endoscopy.
The study will enroll adults with signs/symptoms suggesting Crohn’s disease and non-diagnostic ileocolonoscopy; patency capsule testing is used to exclude stenosis before capsule ingestion. The OMOM system’s SmartScan (a CNN/DNN tool) automatically selects and highlights images and classifies multiple lesion types to create a short reviewable video.
Sites will follow a standardized bowel-preparation regimen and collect clinical, laboratory, and patient-reported outcome data, with follow-up at 6 and 12 months. The trial is observational and recruiting; it aims to evaluate real-world diagnostic accuracy and workflow impact (reading time) rather than test a therapeutic intervention.
Results will help determine whether AI can safely reduce review time without missing typical erosions/ulcers of Crohn’s disease.
This is a prospective multicenter observational trial registration; the record describes study design and procedures but does not provide findings. The OMOM SmartScan is a commercial AI-assisted reading tool; the registry notes standardized prep and follow-up to assess diagnostic yield and safety (including capsule retention).
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
AI-assisted capsule endoscopy may improve detection of Crohn’s disease lesions and reduce missed findings, which could affect diagnosis and monitoring. People with IBD may see faster or more consistent reads of capsule...
Faster, more accurate capsule endoscopy reading could shorten diagnostic delays and reduce missed small‑bowel lesions in Crohn’s disease. For busy clinics, an AI assistant could cut review time and help less‑experienced...
People with Crohn’s disease facing surgery may have varying risks of complications; better biomarkers and models could help tailor perioperative care and decision-making. The review signals active research toward more...
